Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVD

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 27, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 27, 2023 -- Long-term exposure to attention-deficit/hyperactivity disorder (ADHD) medications is associated with an increased risk for cardiovascular disease (CVD), especially hypertension, according to a study published online Nov. 22 in JAMA Psychiatry.

Le Zhang, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the association between long-term ADHD medication use and risk for CVD in a case-control study involving individuals in Sweden aged 6 to 64 years with an incident diagnosis of ADHD or ADHD medication dispensation between Jan. 1, 2007, and Dec. 31, 2020.

The researchers matched 10,388 individuals with CVD with 51,672 controls without CVD. Compared with nonuse, longer cumulative duration of ADHD medication use was associated with an increased risk for CVD (adjusted odds ratios, 1.09, 1.15, 1.27, and 1.23 for one to no more than two years, two to no more than three years, three to no more than five years, and more than five years, respectively). An increased risk for hypertension was seen in association with longer cumulative ADHD medication use (adjusted odds ratios, 1.72 and 1.80 for three to no more than five years and more than five years, respectively); the risk for arterial disease was also increased. Each one-year increase of ADHD medication use was associated with an increased risk for CVD across the 14-year follow-up (adjusted odds ratio, 1.04), with a larger increase seen in the first three years of cumulative use (adjusted odds ratio, 1.08). The patterns were similar for children and youth and for adults.

"Monitoring becomes even more crucial considering the increasing number of individuals engaging in long-term use of ADHD medication," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-28 02:32

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords